Common use of Persons and Addresses Clause in Contracts

Persons and Addresses. Except as may otherwise be provided, all notices or other communications provided for in this Contribution Agreement or that a Party may otherwise be required to give to the other Party shall be sent as provided in Section 10.1 to the following persons at the addresses stated herein or at such other address as either Party may specify by notice to the other Party given in accordance with this Article 10: To CRISPR: CRISPR Therapeutics AG Xxxxxxxxxxxxxxx 00 0000 Xxxxx Xxxxxxxxxxx Attention: Chief Executive Officer and Chief Legal Officer and CRISPR Therapeutics Ltd. 00 Xxxxxxxxx Xxxxx Xxxx Xxxxxx X0X 0XX Xxxxxx Xxxxxxx Attention: Chief Legal Officer [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. With a copy to: Xxxxxxx Procter LLP 00 Xxxxx Xxxxxx Xxxxxx, XX 00000 XXX Attention: Xxxxxxxx X. Xxxxx and Xxxxxx X. Xxxxxxx and Bayer Xxxxxxxxxxxxxxxxxx Xxxxxx-Xxxxxxx-Allee 51368 Leverkusen Germany Attention: Xx. Xxxx Xxxxxxx and Xx. Xxx Xxxxxxxxx Xxxxxx Xxxx Xxxxxxxxx US LLP 000 Xxxxxxxxxxxx Xxxxxx, X.X. Xxxxxxxxxx, X.X. 00000-0000 XXX Attention: Xxxxxxx Xxxxxx To Company: VIVR LLP c/o Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx With a copy to: Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx Solely for purposes of enforcing its rights to receive copies of notices to CRISPR under this Section 10.2, Bayer shall be an express Third Party beneficiary of Section 10.2 of this Contribution Agreement.

Persons and Addresses. Except as may otherwise be provided, all notices or other communications provided for in this Contribution Agreement or that a Party may otherwise be required to give to the other Party shall be sent as provided in Section 10.1 7.1 to the following persons at the addresses stated herein or at such other address as either Party may specify by notice to the other Party given in accordance with this Article 107: To Company: VIVR LLP c/o Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx With a copy to: Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx To CRISPR: CRISPR Therapeutics AG Xxxxxxxxxxxxxxx 00 0000 Xxxxx Xxxxxxxxxxx Attention: Chief Executive Officer and Chief Legal Officer and CRISPR Therapeutics Ltd. 00 Xxxxxxxxx Xxxxx Xxxx Xxxxxx X0X 0XX Xxxxxx Xxxxxxx Attention: Chief Legal Officer [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. With a copy to: Xxxxxxx Procter LLP 00 Xxxxx Xxxxxx Xxxxxx, XX 00000 XXX Attention: Xxxxxxxx X. Xxxxx and Xxxxxx X. Xxxxxxx and Bayer To Xxxxx: Xxxxx Xxxxxxxxxxxxxxxxxx Xxxxxx-Xxxxxxx-Allee 51368 Leverkusen Germany Attention: Xx. Xxxx Xxxxxxx and Xx. Xxx Xxxxxxxxx Xxxxxx With a copy to: Norton Xxxx Xxxxxxxxx US LLP 000 Xxxxxxxxxxxx Xxxxxx, X.X. Xxxxxxxxxx, X.X. 00000-0000 XXX Attention: Xxxxxxx Xxxxxx To Company: VIVR LLP c/o Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx With a copy to: Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx Solely for purposes of enforcing its rights to receive copies of notices to CRISPR under this Section 10.2, Bayer shall be an express Third Party beneficiary of Section 10.2 of this Contribution Agreement.Xxxxxx

Persons and Addresses. Except as may otherwise be provided, all notices or other communications provided for in this Contribution Agreement or that a Party may otherwise be required to give to the other another Party shall be sent as provided in Section 10.1 7.1 to the following persons at the addresses stated herein or at such other address as either a Party may specify by notice to the other Party Parties given in accordance with this Article 107: To Company: VIVR LLP c/o Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx With a copy to: Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx To CRISPR: CRISPR Therapeutics AG Xxxxxxxxxxxxxxx 00 0000 Xxxxx Xxxxxxxxxxx Attention: Chief Executive Officer and Chief Legal Officer and CRISPR Therapeutics Ltd. 00 Xxxxxxxxx Xxxxx Xxxx Xxxxxx X0X 0XX Xxxxxx Xxxxxxx Attention: Chief Legal Officer [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. With a copy to: Xxxxxxx Procter LLP 00 Xxxxx Xxxxxx Xxxxxx, XX 00000 XXX Attention: Xxxxxxxx X. Xxxxx and Xxxxxx X. Xxxxxxx and Bayer To Xxxxx: Xxxxx Xxxxxxxxxxxxxxxxxx Xxxxxx-Xxxxxxx-Allee 51368 Leverkusen Germany Attention: Xx. Xxxx Xxxxxxx and Xx. Xxx Xxxxxxxxx Xxxxxx With a copy to: Norton Xxxx Xxxxxxxxx US LLP 000 Xxxxxxxxxxxx Xxxxxx, X.X. Xxxxxxxxxx, X.X. 00000-0000 XXX Attention: Xxxxxxx Xxxxxx To Company: VIVR LLP c/o Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx With a copy to: Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx Solely for purposes of enforcing its rights to receive copies of notices to CRISPR under this Section 10.2, Bayer shall be an express Third Party beneficiary of Section 10.2 of this Contribution Agreement.Xxxxxx

Persons and Addresses. Except as may otherwise be provided, all notices or other communications provided for in this Contribution Agreement or that a Party may otherwise be required to give to the other Party shall be sent as provided in Section 10.1 9.1 to the following persons at the addresses stated herein or at such other address as either Party may specify by notice to the other Party given in accordance with this Article 109: To CRISPRCompany: VIVR LLP c/o Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attention: Xxxxxx Xxxxx With a copy to: Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attention: Xxxxxx Xxxxx To Bayer: Bayer Xxxxxxxxxxxxxxxxxx Xxxxxx-Xxxxxxx-Allee 51368 Leverkusen Germany Attention: Xx. Xxxx Xxxxxxx and Xx. Xxx Xxxxxxxxx With a copy to: Norton Xxxx Xxxxxxxxx US LLP 000 Xxxxxxxxxxxx Xxxxxx, X.X. Xxxxxxxxxx, X.X. 00000-0000 XXX Attention: Xxxxxxx Xxxxxx CRISPR Therapeutics AG Xxxxxxxxxxxxxxx 00 0000 Xxxxx Xxxxxxxxxxx Attention: Chief Executive Officer and Chief Legal Officer and CRISPR Therapeutics Ltd. 00 Xxxxxxxxx Xxxxx Xxxx Xxxxxx X0X 0XX Xxxxxx Xxxxxxx Attention: Chief Legal Officer And Xxxxxxx Procter LLP 00 Xxxxx Xxxxxx Xxxxxx, XX 00000 XXX Attention: Xxxxxxxx X. Xxxxx and Xxxxxx X. Xxxxxxx [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. With a copy to: Xxxxxxx Procter LLP 00 Xxxxx Xxxxxx Xxxxxx, XX 00000 XXX Attention: Xxxxxxxx X. Xxxxx and Xxxxxx X. Xxxxxxx and Bayer Xxxxxxxxxxxxxxxxxx Xxxxxx-Xxxxxxx-Allee 51368 Leverkusen Germany Attention: Xx. Xxxx Xxxxxxx and Xx. Xxx Xxxxxxxxx Xxxxxx Xxxx Xxxxxxxxx US LLP 000 Xxxxxxxxxxxx Xxxxxx, X.X. Xxxxxxxxxx, X.X. 00000-0000 XXX Attention: Xxxxxxx Xxxxxx To Company: VIVR LLP c/o Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx With a copy to: Xxxxxx Xxxxxxx 0 Xxx Xxxxxx Xxxxxx Xxxxxx XX0X 0XX Attn: Xxxxxx Xxxxx Solely for purposes of enforcing its rights to receive copies of notices to CRISPR Bayer under this Section 10.29.2, Bayer CRISPR shall be an express Third Party beneficiary of Section 10.2 9.2 of this Contribution Agreement.